Industry: Pharmaceuticals, Biotechnology
National Stem Cell is also developing a platform that will allow for the growth of contaminant-free human embryonic stem (hES) cell lines which will then be made available to the research community. This new platform has the promise to become the backbone of future stem cell research. We also intend to establish the National Stem Cell Cord Blood Bank to meet the growing need for transplant grade umbilical cord blood stem cells which have been identified as a potential treatment for more than 80 diseases ranging from leukemia to sickle cell ( www.nationalstemcell.com )
National Stem Cell , Inc.
17 State Street 39Th Floor
New York, New York 10004
USA
Tel: (212) 792-6160